These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 17183845)

  • 1. Does c-erbB-2 expression have a role in medulloblastoma prognosis?
    Bal MM; Das Radotra B; Srinivasan R; Sharma SC
    Indian J Pathol Microbiol; 2006 Oct; 49(4):535-9. PubMed ID: 17183845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma.
    Abd El-Rehim DM; Pinder SE; Paish CE; Bell JA; Rampaul RS; Blamey RW; Robertson JF; Nicholson RI; Ellis IO
    Br J Cancer; 2004 Oct; 91(8):1532-42. PubMed ID: 15480434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor (EGFR) expression in childhood brain tumors.
    Bodey B; Kaiser HE; Siegel SE
    In Vivo; 2005; 19(5):931-41. PubMed ID: 16097449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma.
    Gilbertson RJ; Perry RH; Kelly PJ; Pearson AD; Lunec J
    Cancer Res; 1997 Aug; 57(15):3272-80. PubMed ID: 9242460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative prognostic impact of the coexpression of epidermal growth factor receptor and c-erbB-2 in locally advanced cervical cancer.
    Pérez-Regadera J; Sánchez-Muñoz A; De-la-Cruz J; Ballestín C; Lora D; García-Martín R; Mendiola C; Alonso L; Alba E; Lanzós E
    Oncology; 2009; 76(2):133-41. PubMed ID: 19174612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathological prognostic factors in medulloblastoma: high expression of survivin is related to unfavourable outcome.
    Haberler C; Slavc I; Czech T; Gelpi E; Heinzl H; Budka H; Urban C; Scarpatetti M; Ebetsberger-Dachs G; Schindler C; Jones N; Klein-Franke A; Maier H; Jauk B; Kiefer A; Hainfellner JA
    Eur J Cancer; 2006 Nov; 42(17):2996-3003. PubMed ID: 16996732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of the co-expression of p53 and c-erbB-2 proteins in breast cancer.
    Nakopoulou LL; Alexiadou A; Theodoropoulos GE; Lazaris AC; Tzonou A; Keramopoulos A
    J Pathol; 1996 May; 179(1):31-8. PubMed ID: 8691341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of c-erbB-4 in medulloblastoma and its correlation with prognosis.
    Bal MM; Das Radotra B; Srinivasan R; Sharma SC
    Histopathology; 2006 Jul; 49(1):92-3. PubMed ID: 16842254
    [No Abstract]   [Full Text] [Related]  

  • 9. EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival.
    Suo Z; Risberg B; Kalsson MG; Willman K; Tierens A; Skovlund E; Nesland JM
    J Pathol; 2002 Jan; 196(1):17-25. PubMed ID: 11748637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma--a prospective study.
    Ma BB; Poon TC; To KF; Zee B; Mo FK; Chan CM; Ho S; Teo PM; Johnson PJ; Chan AT
    Head Neck; 2003 Oct; 25(10):864-72. PubMed ID: 12966511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas.
    Ettl T; Schwarz S; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
    Histopathology; 2008 Nov; 53(5):567-77. PubMed ID: 18983466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calbindin-d(28k): a marker of recurrence for medulloblastomas.
    Pelc K; Vincent S; Ruchoux MM; Kiss R; Pochet R; Sariban E; Decaestecker C; Heizmann CW
    Cancer; 2002 Jul; 95(2):410-9. PubMed ID: 12124842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival.
    Giatromanolaki A; Koukourakis MI; Sivridis E; Fountzilas G
    Anticancer Res; 2000; 20(2A):997-1004. PubMed ID: 10810387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of c-erbB2 expression in breast cancer.
    Tsutsui S; Ohno S; Murakami S; Hachitanda Y; Oda S
    J Surg Oncol; 2002 Apr; 79(4):216-23. PubMed ID: 11920778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of c-erbB-2 protein in normal and neoplastic urothelium: lack of adverse prognostic effect in human urinary bladder cancer.
    Lee SE; Chow NH; Chi YC; Tzai TS; Yang WH; Lin SN
    Anticancer Res; 1994; 14(3B):1317-24. PubMed ID: 7915094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of HER2neu (c-erbB-2) and epidermal growth factor receptor in cervical cancer: prognostic correlation with clinical characteristics, and comparison of manual and automated imaging analysis.
    Lee CM; Lee RJ; Hammond E; Tsodikov A; Dodson M; Zempolich K; Gaffney DK
    Gynecol Oncol; 2004 Apr; 93(1):209-14. PubMed ID: 15047238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer.
    McCann AH; Dervan PA; O'Regan M; Codd MB; Gullick WJ; Tobin BM; Carney DN
    Cancer Res; 1991 Jun; 51(12):3296-303. PubMed ID: 1674898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of c-erbB proto-oncogene family members in squamous cell carcinoma of the head and neck.
    Ibrahim SO; Vasstrand EN; Liavaag PG; Johannessen AC; Lillehaug JR
    Anticancer Res; 1997; 17(6D):4539-46. PubMed ID: 9494565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexpression of c-erbB 1-4 receptor proteins in human glioblastomas. An immunohistochemical study.
    Torp SH; Gulati S; Johannessen E; Dalen A
    J Exp Clin Cancer Res; 2007 Sep; 26(3):353-9. PubMed ID: 17987795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications.
    Rudolph P; Olsson H; Bonatz G; Ratjen V; Bolte H; Baldetorp B; Fernö M; Parwaresch R; Alm P
    J Pathol; 1999 Jan; 187(2):207-16. PubMed ID: 10365096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.